CD8A and parasitic infectious disease: Recombinant Leishmania donovani HASPB is a target for recognition by B-1 B cell-derived natural antibodies, with the resulting immune complexes triggering classical complement pathway activation, leading to IL-4 secretion, CD8+ T cell priming and vaccination against parasite infection in immuno-compromised mice (Stager et al., 2003).